LBF20308PG03: Difference between revisions
No edit summary |
No edit summary |
||
| Line 14: | Line 14: | ||
|NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H-NMR(CDCl<SUB><FONT SIZE=-1>3</FONT></SUB>) : <FONT FACE="Symbol">d</FONT> 7.5(dd, 1H, 9-CH), 6.56(t, 1H, 13-CH), 6.35(dd,1 H, 10-CH), 5.48(m, 2H, 5,6-CH), 3.88(m, 1H, 15-CH), 3.44(m, 1H, 8-CH) [[Reference:Kikawa_Y:Narumiya_S:Fukushima_M:Wakatsuka_H:Hayaishi_O:,Proc. Natl. Acad. Sci. U. S. A.,1984,81,1317|{{RelationTable/GetFirstAuthor|Reference:Kikawa_Y:Narumiya_S:Fukushima_M:Wakatsuka_H:Hayaishi_O:,Proc. Natl. Acad. Sci. U. S. A.,1984,81,1317}}]] | |NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H-NMR(CDCl<SUB><FONT SIZE=-1>3</FONT></SUB>) : <FONT FACE="Symbol">d</FONT> 7.5(dd, 1H, 9-CH), 6.56(t, 1H, 13-CH), 6.35(dd,1 H, 10-CH), 5.48(m, 2H, 5,6-CH), 3.88(m, 1H, 15-CH), 3.44(m, 1H, 8-CH) [[Reference:Kikawa_Y:Narumiya_S:Fukushima_M:Wakatsuka_H:Hayaishi_O:,Proc. Natl. Acad. Sci. U. S. A.,1984,81,1317|{{RelationTable/GetFirstAuthor|Reference:Kikawa_Y:Narumiya_S:Fukushima_M:Wakatsuka_H:Hayaishi_O:,Proc. Natl. Acad. Sci. U. S. A.,1984,81,1317}}]] | ||
|Source= | |Source= | ||
|Chemical Synthesis=[[Reference:Bundy_GL:Morton_DR:Peterson_DC:Nishizawa_EE:Miller_WL:,J. Med. Chem.,1983,26,790|{{RelationTable/GetFirstAuthor|Reference:Bundy_GL:Morton_DR:Peterson_DC:Nishizawa_EE:Miller_WL:,J. Med. Chem.,1983,26,790}}]] | |Chemical Synthesis=[[Reference:Bundy_GL:Morton_DR:Peterson_DC:Nishizawa_EE:Miller_WL:,J. Med. Chem.,1983,26,790|{{RelationTable/GetFirstAuthor|Reference:Bundy_GL:Morton_DR:Peterson_DC:Nishizawa_EE:Miller_WL:,J. Med. Chem.,1983,26,790}}]] {{Image200|LBF20308PG03FT0001.gif}} | ||
|Metabolism=In human plasma prostaglandin D2 is dehydrated and converted to 9-deoxy-<FONT FACE="Symbol">D</FONT>9,12-13,14-dihydro-prostaglandin D2 (<FONT FACE="Symbol">D</FONT>12-prostaglandin J2) catalyzedby serum albumin [[Reference:Narumiya_S:Fukushima_M:,Biochem. Biophys. Res. Commun.,1985,127,739|{{RelationTable/GetFirstAuthor|Reference:Narumiya_S:Fukushima_M:,Biochem. Biophys. Res. Commun.,1985,127,739}}]] | |Metabolism=In human plasma prostaglandin D2 is dehydrated and converted to 9-deoxy-<FONT FACE="Symbol">D</FONT>9,12-13,14-dihydro-prostaglandin D2 (<FONT FACE="Symbol">D</FONT>12-prostaglandin J2) catalyzedby serum albumin [[Reference:Narumiya_S:Fukushima_M:,Biochem. Biophys. Res. Commun.,1985,127,739|{{RelationTable/GetFirstAuthor|Reference:Narumiya_S:Fukushima_M:,Biochem. Biophys. Res. Commun.,1985,127,739}}]]. | ||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Revision as of 11:55, 25 November 2009
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1911 |
| LipidMaps | - |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20308PG03 |
| 7- [ 2 (E) - (3 (S) -Hydroxyoctylidene) -3-oxo-4-cyclopenten-1 (R) -yl ] -5 (Z) -heptenoic acid | |
|---|---|
| |
| Structural Information | |
| 7- [ 2 (E) - (3 (S) -Hydroxyoctylidene) -3-oxo-4-cyclopenten-1 (R) -yl ] -5 (Z) -heptenoic acid | |
| |
| Formula | C20H30O4 |
| Exact Mass | 334.21440944799997 |
| Average Mass | 334.4498 |
| SMILES | C(CC[C@@H](O)CC=C(C(=O)1)[C@@H](CC=CCCCC(O)=O)C=C1)CC |
| Physicochemical Information | |
| METHANOL Fitzpatrick_FA et al.ETHANOL, CHLOROFORM, ETHYL ACETATE KikawaYet al. | |
Bundy_GL et al.  | |
| In human plasma prostaglandin D2 is dehydrated and converted to 9-deoxy-D9,12-13,14-dihydro-prostaglandin D2 (D12-prostaglandin J2) catalyzedby serum albumin Narumiya_S et al.. | |
| Spectral Information | |
| Mass Spectra | m/e 334(M+), 316, 245, 236 KikawaYet al. |
| UV Spectra | l EtOHmax = 244(e 6100)nm KikawaYet al. |
| IR Spectra | n : 2930, 1700, 1640, 1580, 1232, 028 cm-1 KikawaYet al. |
| NMR Spectra | 1H-NMR(CDCl3) : d 7.5(dd, 1H, 9-CH), 6.56(t, 1H, 13-CH), 6.35(dd,1 H, 10-CH), 5.48(m, 2H, 5,6-CH), 3.88(m, 1H, 15-CH), 3.44(m, 1H, 8-CH) KikawaYet al. |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
